Location History:
- Brisbane, CA (US) (2020 - 2021)
- South San Francisco, CA (US) (2024)
Company Filing History:
Years Active: 2020-2024
Title: The Innovative Contributions of Harry Sweigard
Introduction
Harry Sweigard is a notable inventor based in Brisbane, California. He has made significant contributions to the field of ophthalmology through his innovative research and inventions. With a total of 3 patents, Sweigard's work focuses on addressing age-related eye conditions.
Latest Patents
One of Harry Sweigard's latest patents is centered around methods of inhibiting pathological angiogenesis. This invention is based on the discovery that many eye conditions associated with aging are mediated at least in part by cells bearing a senescent phenotype. Senescent cells accumulate with age and express factors that contribute to the pathophysiology of age-related conditions. The data show that in age-matched patients, the severity of age-related conditions correlates with the abundance of senescent cells. Clearing senescent cells can help abrogate these conditions. Sweigard's invention provides small molecule drugs that remove senescent cells from affected tissue in the eye, demonstrating special efficacy in treating ophthalmic conditions. These drugs not only inhibit the progression of the disease but can also reverse some of the pathophysiology, such as neovascularization and vaso-obliteration, that lead to vision loss. The senolytic agents developed by Sweigard have an appropriate dose and specificity profile to be effective in the clinical management of previously intractable ophthalmic conditions.
Career Highlights
Harry Sweigard is currently associated with Unity Biotechnology, Inc., where he continues to advance his research in the field of ophthalmology. His work has garnered attention for its potential to significantly improve the quality of life for individuals suffering from age-related eye conditions.
Collaborations
Some of Harry Sweigard's coworkers include Pam Tsuruda and Jill Hopkins, who contribute to the collaborative efforts at Unity Biotechnology, Inc. Their combined expertise enhances the innovative environment in which they work.
Conclusion
Harry Sweigard's contributions to the field of ophthalmology through his innovative patents highlight the importance of addressing age-related conditions. His work not only provides new treatment options but also paves the way for future advancements in medical science.